Objective: There are a number of cardiac output (CO) monitors that could potentially be used in the ED. Two of the most promising methods, thoracic electrical bioimpedance and suprasternal Doppler, have not been directly compared. The aim of this study was to investigate the feasibility of CO monitoring using suprasternal Doppler and bioimpedance in emergency care and compare haemodynamic data obtained from both monitors. Methods: Haemodynamic measurements were made on the same group of patients using bioimpedance (Niccomo, Medis, Germany) and suprasternal Doppler (USCOM, Sydney, Australia). Results: Usable CO data were obtained in 97% of patients by suprasternal Doppler and 87% by bioimpedance. The median CO obtained by Doppler was 3.4 L/min lower than bioimpedance. The stroke volume median was lower by 51 mL in Doppler. Conclusions: These two methods of non-invasive cardiac monitoring are not interchangeable. The results suggest that the choice of non-invasive cardiac monitor is important, but the grounds on which to make this choice are not currently clear.
Background
Despite recent advances in haemodynamic monitoring, EDs still rely on physical examination and basic monitoring parameters (e.g. blood pressure and heart rate). 1, 2 Direct measurement of cardiac output (CO) has been suggested as a more accurate method. Several noninvasive CO monitors have been developed, rendering this approach more relevant to emergency care. 3 It has been suggested that thoracic electrical bioimpedance and suprasternal Doppler may be most feasible in the ED. 4 Bioimpedance devices apply a small electrical current across the chest and continuously measure impedance, and calculate CO from impedance changes. 5 Suprasternal Doppler uses ultrasound flow tracings to calculate CO as the product of the stroke volume (SV) and heart rate. 6 Although both devices gained much attention in emergency medicine, there has been no previous comparisons. We aim to investigate the feasibility of suprasternal Doppler and bioimpedance in emergency care and compare the absolute haemodynamic data obtained from both monitors.
Methods
The study was carried out in the ED of the Leicester Royal Infirmary, UK. Ethical approval was granted by the local research ethics committee. Participants were recruited as part of the Diagnostics Development Unit (DDU) protocol between 2012 and 2016. The DDU investigated noninvasive monitors in a cross-sectional sample of ED attendants. Inclusion criteria were age more than 18 years and ability to consent. Prisoners and mental health patients were excluded. Informed consent was obtained in all cases before enrolment.
Patients had cardiovascular data measured by one of two trained operators using both the Niccomo (Medis, Germany) bioimpedance monitor and the USCOM (Sydney, Australia) suprasternal Doppler device. 7, 8 Niccomo electrodes were
• Suprasternal Doppler gave lower than expected cardiac output data suggesting that the two methods are not interchangeable.
• Bioimpedance gave less usable recordings suggesting higher practical difficulty.
attached to the sides of the neck and lower chest. Continuous haemodynamic data were recorded over around 20 min. Between one and five readings were taken using the USCOM. The median CO, SV and heart rate were calculated for each method. The agreement between the two methods was assessed using Bland-Altman plot. 9 
Results
We recruited 149 patients, of which full CO data set for both methods was achieved in 128 patients (97% in suprasternal Doppler and 87% in bioimpedance) -data loss due to technical failure or patient discomfort. A total of 56% were men, with a median age of 49 (interquartile range [IQR] 34-68) and median mean arterial pressure of 95 (IQR, 87-109). Quick Sequential Organ Failure Assessment score was <2 in all but one patient. The bioimpedance CO readings were 3.4 L/min higher than with Doppler, with SV also higher by 51 mL (Table 1) . Most of the bioimpedance readings were within the expected normal range of CO, whereas most of the Doppler readings were below the expected range (Fig. 1) . The Bland-Altman plot of the CO results showed the difference between the methods, with a similar pattern across the range of CO values (Fig. 2) .
Discussion
Our data show that monitoring was more feasible by suprasternal Doppler. This indicates the technical challenges of these new monitoring techniques in the emergency care environment -with more difficulty for continuous monitoring in bioimpedance instance. However, all of the patients in this study were relatively well, so the feasibility of both monitors needs to be assessed again if their use was contemplated in higher severity patients.
Our finding of a consistently lower recording with suprasternal Doppler than bioimpedance is consistent with a previous finding that suprasternal Doppler may have a systematic tendency to underestimate CO. 6 Both monitors have been previously validated against thermodilution. However, most validation studies were carried out in a controlled setting in intensive care units or perioperatively, 6 ,10 so may not apply to the less controlled setting and more heterogeneous patients in the ED.
There is some operator dependence in the Doppler methods, as small changes in probe position can affect the readings, and it could be that there was a systematic operator effect giving lower readings in this study. The bioimpedance method does not require a skilled operator, and there is therefore less potential for operator variability. However, this seemed to be at the expense of more practical difficulty.
The main limitation to this study is the lack of a reference standard (and the fact that there is no agreement in the literature with what the reference standard should be). However, as most of the patients were not seriously ill, it is likely that they should have had CO readings within the normal range. Another limitation is the convenience sample over a long period of time, which may be subject to bias. In this brief report, we did not assess the ability of both monitors to follow trends in CO, as all of the patients were in a stable state. In acute care, reliable real-time tracking of the direction of changes in CO is arguably more important than the ability of the monitor to deliver a highly accurate single measurement.
11 Limited number of studies examined the trending ability of bioimpedance and suprasternal Doppler, 12 so this is an area that requires further research.
The lack of an established reference standard in this area leads to some important philosophical questions about the pathway for the assessment of devices in emergency care. In the early stages of development of a monitoring device it should be assessed against a 'gold standard' to assess whether or not it measures what it says that it is measuring. This is a requirement for the 'CE mark' (Conformité Européene), for which non-invasive CO monitors are often validated against a reference standard of an invasive technique. However, in later stage development to assess whether or not a device is useful in emergency care the clinically important comparison is with 'standard care' -the currently used ED surrogates of cardiac function using clinical examination, pulse rate, capillary refill and blood pressure. To determine if a device should change practice in clinical care 'Better than the current parameters' is the requirement rather than 'As good as an artificial gold standard'. From the data presented here, it is not possible to conclude which of the methods that we studied is 'better'; however, it can be concluded that the methods are not the same, and that the suprasternal Doppler gave lower readings than we expected. This implies that the choice of method is important in emergency care cardiac monitoring research. Unfortunately at present the information available about different methods is not sufficient to make a firm recommendation; however, our experience in comparing these two methods has led us to decide to use bioimpedance in future research, as it does not require a skilled operator and gave readings within the range that was expected.
